Kenneth J. Kelley serves as Executive at HALOZYME THERAPEUTICS INC, where they oversee executive responsibilities. Since joining the company, Kenneth J. Kelley has executed 257 insider transactions totaling $8.8M, demonstrating a bearish approach to their equity position. Their most recent transaction on Mar 14, 2007 involved selling 1,200 shares valued at $9.4K.
Kenneth J. Kelley currently holds 179,833 shares of HALOZYME THERAPEUTICS INC (HTI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Kenneth J. Kelley has been a net seller of HTI stock. They have purchased $1.0M and sold $7.8M worth of shares.
Kenneth J. Kelley's most recent insider trade was on Mar 14, 2007, when they sold 1,200 shares at $7.86 per share.
Get notified when new Form 4 filings are submitted
| $7.85 |
| Discretionary |
| Mar 14, 2007 | HTI | $1.6K | Sale | 200 | $7.84 | Discretionary |
| Mar 14, 2007 | HTI | $3.1K | Sale | 400 | $7.83 | Discretionary |
| Mar 14, 2007 | HTI | $22.5K | Sale | 2,800 | $8.05 | Discretionary |
| Mar 14, 2007 | HTI | $51.3K | Option Exercise | 25,000 | $2.05 | Discretionary |
| May 4, 2006 | HTI | $42.0K | Award | 15,000 | $2.80 | Discretionary |